Title : A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.

Pub. Date : 2007 Dec 3

PMID : 18040273






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib has antitumour activity in HRPCP when evaluated for RECIST- and PSA-based response. Sorafenib kallikrein related peptidase 3 Homo sapiens